{
  "approaches": [
    {
      "aliases": ["health-system-accountability--prescription-drug-pricing"],
      "analysis_frame": {
        "cause": "The theory is that market power, patent leverage, and fragmented purchasing keep drug prices high.",
        "evaluation_questions": [
          "Which actor is being held accountable?",
          "Is the tool enforcement, litigation, price leverage, or market oversight?",
          "What source evidence shows that prescription drug price controls addresses the stated problem rather than just naming a topic?",
          "Which assumptions would have to be true for this to work in practice?",
          "Who pays, who benefits, and what gets worse if this approach is implemented?"
        ],
        "evidence_needed": [
          "Comparable candidate sources that name the same problem and policy lever.",
          "Independent or administrative data that tests whether the lever can plausibly change outcomes."
        ],
        "evidence_signal": "The node mixes state and federal price-leverage examples, so source rows should be read for jurisdiction and tool.",
        "plausibility": "Plausible when government purchasing has scale and legal authority; weaker for drugs outside the covered program.",
        "possible_solution": "Use CalRx, public purchasing, negotiation, or price-control tools to lower drug costs.",
        "problem": "Prescription drugs can remain unaffordable even for insured patients when public purchasers lack price leverage.",
        "problem_kind": "policy_problem",
        "related_problems": ["Health premiums", "Consumer affordability", "Federal health policy"],
        "tradeoffs": [
          "Can lower prices for covered drugs, but may face industry resistance or supply concerns.",
          "Savings depend on which drugs and patients are included."
        ]
      },
      "approach_id": "health-system-accountability--prescription-drug-pricing",
      "candidate_count": 1,
      "cause": "The theory is that market power, patent leverage, and fragmented purchasing keep drug prices high.",
      "claim_count": 2,
      "confidence": 0.53,
      "coverage_notes": ["Only one candidate currently has source rows here."],
      "coverage_score": 37,
      "deduped_evidence_count": 2,
      "evidence": [
        {
          "candidate_id": "xavier-becerra",
          "candidate_name": "Xavier Becerra",
          "claim_id": "cl-app-event-xavier-becerra-2023-08-29-research-seed-oversaw-hhs-cms-implem-e0db9103",
          "claim_type": "observation",
          "date": "2023-08-29",
          "event_id": "event-xavier-becerra-2023-08-29-research-seed-oversaw-hhs-cms-implementation-s-9874a1e6",
          "event_title": "Oversaw HHS/CMS implementation step for Medicare drug price negotiation",
          "matched_keywords": ["drug", "medicare drug price negotiation", "selected drugs"],
          "party": "Democratic",
          "source_url": "https://www.cms.gov/newsroom/press-releases/statements-cms-leadership-historic-announcement-first-selected-drugs-medicare-drug-price-negotiation",
          "stance": "record",
          "stance_confidence": 0.72,
          "stance_reason": "record_observation",
          "text": "Oversaw HHS/CMS implementation step for Medicare drug price negotiation: CMS announced the first selected drugs for the Medicare Drug Price Negotiation Program while Becerra led HHS.",
          "theme_id": "prescription-drugs",
          "theme_label": "Prescription Drugs"
        },
        {
          "candidate_id": "xavier-becerra",
          "candidate_name": "Xavier Becerra",
          "claim_id": "cl-app-event-2026-05-05-cnn-california-governor-primary-debate-xavier-becer-6195c223",
          "claim_type": "assertion",
          "date": "2026-05-05",
          "event_id": "event-2026-05-05-cnn-california-governor-primary-debate",
          "event_title": "CNN California governor primary debate",
          "matched_keywords": ["drug", "drug prices"],
          "party": "Democratic",
          "source_url": "https://ktvz.com/politics/cnn-us-politics/2026/05/05/key-moments-from-cnns-california-governor-primary-debate/",
          "stance": "support",
          "stance_confidence": 0.7,
          "stance_reason": "support_language",
          "text": "Becerra says that as U.S. secretary of Health and Human Services he expanded health care access and negotiated lower Medicare drug prices, claiming price reductions of up to 80%.",
          "theme_id": "health-care",
          "theme_label": "Health Care"
        }
      ],
      "evidence_groups": [
        {
          "candidate_id": "xavier-becerra",
          "candidate_name": "Xavier Becerra",
          "claim_ids": [
            "cl-app-event-2026-05-05-cnn-california-governor-primary-debate-xavier-becer-6195c223"
          ],
          "claim_type": "assertion",
          "date": "2026-05-05",
          "group_id": "idea:health-system-accountability:prescription-drug-pricing:evidence:xavier-becerra:support:a641daf298",
          "matched_keywords": ["drug", "drug prices"],
          "party": "Democratic",
          "row_count": 1,
          "source_count": 1,
          "source_rows": [
            {
              "claim_id": "cl-app-event-2026-05-05-cnn-california-governor-primary-debate-xavier-becer-6195c223",
              "date": "2026-05-05",
              "event_id": "event-2026-05-05-cnn-california-governor-primary-debate",
              "event_title": "CNN California governor primary debate",
              "source_url": "https://ktvz.com/politics/cnn-us-politics/2026/05/05/key-moments-from-cnns-california-governor-primary-debate/",
              "text": "Becerra says that as U.S. secretary of Health and Human Services he expanded health care access and negotiated lower Medicare drug prices, claiming price reductions of up to 80%."
            }
          ],
          "stance": "support",
          "statement": "Becerra says that as U.S. secretary of Health and Human Services he expanded health care access and negotiated lower Medicare drug prices, claiming price reductions of up to 80%."
        },
        {
          "candidate_id": "xavier-becerra",
          "candidate_name": "Xavier Becerra",
          "claim_ids": [
            "cl-app-event-xavier-becerra-2023-08-29-research-seed-oversaw-hhs-cms-implem-e0db9103"
          ],
          "claim_type": "observation",
          "date": "2023-08-29",
          "group_id": "idea:health-system-accountability:prescription-drug-pricing:evidence:xavier-becerra:record:2a3b0eecc1",
          "matched_keywords": ["drug", "medicare drug price negotiation", "selected drugs"],
          "party": "Democratic",
          "row_count": 1,
          "source_count": 1,
          "source_rows": [
            {
              "claim_id": "cl-app-event-xavier-becerra-2023-08-29-research-seed-oversaw-hhs-cms-implem-e0db9103",
              "date": "2023-08-29",
              "event_id": "event-xavier-becerra-2023-08-29-research-seed-oversaw-hhs-cms-implementation-s-9874a1e6",
              "event_title": "Oversaw HHS/CMS implementation step for Medicare drug price negotiation",
              "source_url": "https://www.cms.gov/newsroom/press-releases/statements-cms-leadership-historic-announcement-first-selected-drugs-medicare-drug-price-negotiation",
              "text": "Oversaw HHS/CMS implementation step for Medicare drug price negotiation: CMS announced the first selected drugs for the Medicare Drug Price Negotiation Program while Becerra led HHS."
            }
          ],
          "stance": "record",
          "statement": "Oversaw HHS/CMS implementation step for Medicare drug price negotiation: CMS announced the first selected drugs for the Medicare Drug Price Negotiation Program while Becerra led HHS."
        }
      ],
      "evidence_quality": "single_candidate",
      "evidence_signal": "The node mixes state and federal price-leverage examples, so source rows should be read for jurisdiction and tool.",
      "idea_id": "idea:health-system-accountability:prescription-drug-pricing",
      "idea_kind": "policy",
      "idea_slug": "prescription-drug-pricing",
      "issue_id": "health-system-accountability",
      "label": "Prescription drug price controls",
      "matched_keywords": [
        {
          "count": 2,
          "keyword": "drug"
        },
        {
          "count": 1,
          "keyword": "medicare drug price negotiation"
        },
        {
          "count": 1,
          "keyword": "selected drugs"
        },
        {
          "count": 1,
          "keyword": "drug prices"
        }
      ],
      "party_aggregates": [
        {
          "candidate_count": 1,
          "claim_count": 2,
          "issue_candidate_count": 1,
          "party": "Democratic"
        }
      ],
      "plausibility": "Plausible when government purchasing has scale and legal authority; weaker for drugs outside the covered program.",
      "problem": "Prescription drugs can remain unaffordable even for insured patients when public purchasers lack price leverage.",
      "quality_flags": ["single_candidate"],
      "related_problem_links": [],
      "related_problems": ["Health premiums", "Consumer affordability", "Federal health policy"],
      "review_status": "generated_review_candidate",
      "semantic_group_id": "idea-group:health-system-accountability:market-and-program-enforcement",
      "semantic_group_label": "Market and program enforcement",
      "semantic_group_slug": "market-and-program-enforcement",
      "solution": "Use CalRx, public purchasing, negotiation, or price-control tools to lower drug costs.",
      "source_count": 2,
      "stance_counts": {
        "oppose": 0,
        "qualify": 0,
        "record": 1,
        "support": 1,
        "unclear": 0
      },
      "summary": "Uses CalRx, public purchasing, or other tools to reduce prescription drug prices.",
      "tradeoffs": [
        "Can lower prices for covered drugs, but may face industry resistance or supply concerns.",
        "Savings depend on which drugs and patients are included."
      ],
      "variants": [
        {
          "candidate_count": 1,
          "claim_ids": [
            "cl-app-event-2026-05-05-cnn-california-governor-primary-debate-xavier-becer-6195c223",
            "cl-app-event-xavier-becerra-2023-08-29-research-seed-oversaw-hhs-cms-implem-e0db9103"
          ],
          "evidence_count": 2,
          "label": "drug",
          "matched_keyword": "drug",
          "matched_keywords": ["drug"],
          "slug": "drug",
          "source_count": 2,
          "variant_id": "idea:health-system-accountability:prescription-drug-pricing:drug"
        },
        {
          "candidate_count": 1,
          "claim_ids": [
            "cl-app-event-2026-05-05-cnn-california-governor-primary-debate-xavier-becer-6195c223"
          ],
          "evidence_count": 1,
          "label": "drug prices",
          "matched_keyword": "drug prices",
          "matched_keywords": ["drug prices"],
          "slug": "drug-prices",
          "source_count": 1,
          "variant_id": "idea:health-system-accountability:prescription-drug-pricing:drug-prices"
        },
        {
          "candidate_count": 1,
          "claim_ids": [
            "cl-app-event-xavier-becerra-2023-08-29-research-seed-oversaw-hhs-cms-implem-e0db9103"
          ],
          "evidence_count": 1,
          "label": "medicare drug price negotiation",
          "matched_keyword": "medicare drug price negotiation",
          "matched_keywords": ["medicare drug price negotiation"],
          "slug": "medicare-drug-price-negotiation",
          "source_count": 1,
          "variant_id": "idea:health-system-accountability:prescription-drug-pricing:medicare-drug-price-negotiation"
        },
        {
          "candidate_count": 1,
          "claim_ids": [
            "cl-app-event-xavier-becerra-2023-08-29-research-seed-oversaw-hhs-cms-implem-e0db9103"
          ],
          "evidence_count": 1,
          "label": "selected drugs",
          "matched_keyword": "selected drugs",
          "matched_keywords": ["selected drugs"],
          "slug": "selected-drugs",
          "source_count": 1,
          "variant_id": "idea:health-system-accountability:prescription-drug-pricing:selected-drugs"
        }
      ]
    },
    {
      "aliases": ["health-system-accountability--aca-nondiscrimination-enforcement"],
      "analysis_frame": {
        "cause": "The theory is that legal rollbacks expose protected groups to discrimination in health-care access.",
        "evaluation_questions": [
          "Which actor is being held accountable?",
          "Is the tool enforcement, litigation, price leverage, or market oversight?",
          "What source evidence shows that aca nondiscrimination enforcement addresses the stated problem rather than just naming a topic?",
          "Which assumptions would have to be true for this to work in practice?",
          "Who pays, who benefits, and what gets worse if this approach is implemented?"
        ],
        "evidence_needed": [
          "A source naming the protected group, right, enforcement tool, and remedy.",
          "Authority analysis showing which state or local institution can implement it."
        ],
        "evidence_signal": "This is mostly record-backed legal enforcement, so it should be read as rights protection with limited current-campaign coverage.",
        "plausibility": "Plausible when courts or agencies can restore clear rules; limited by federal policy and litigation timelines.",
        "possible_solution": "Use litigation, coalition action, or enforcement to protect ACA nondiscrimination and Section 1557 rules.",
        "problem": "Health access can be weakened when nondiscrimination protections are rolled back or unenforced.",
        "problem_kind": "policy_problem",
        "related_problems": ["Civil rights", "Health access", "Federal health policy"],
        "tradeoffs": [
          "Can protect access for vulnerable groups, but legal wins may be slow and reversible.",
          "Rights enforcement does not solve affordability or provider capacity by itself."
        ]
      },
      "approach_id": "health-system-accountability--aca-nondiscrimination-enforcement",
      "candidate_count": 1,
      "cause": "The theory is that legal rollbacks expose protected groups to discrimination in health-care access.",
      "claim_count": 1,
      "confidence": 0.51,
      "coverage_notes": [
        "Only one candidate currently has source rows here.",
        "Coverage comes from one source URL.",
        "Rows are record signals, not current policy commitments."
      ],
      "coverage_score": 10,
      "deduped_evidence_count": 1,
      "evidence": [
        {
          "candidate_id": "xavier-becerra",
          "candidate_name": "Xavier Becerra",
          "claim_id": "cl-app-event-xavier-becerra-2020-06-22-research-seed-led-multistate-litigat-7a4a5986",
          "claim_type": "observation",
          "date": "2020-06-22",
          "event_id": "event-xavier-becerra-2020-06-22-research-seed-led-multistate-litigation-challe-da46bffc",
          "event_title": "Led multistate litigation challenging rollback of ACA nondiscrimination protections",
          "matched_keywords": [
            "aca",
            "coalition lawsuit",
            "litigation",
            "nondiscrimination",
            "rollback",
            "section 1557"
          ],
          "party": "Democratic",
          "source_url": "https://www.oag.ca.gov/news/press-releases/attorney-general-becerra-files-lawsuit-challenging-trump-administration%E2%80%99s-rule-0",
          "stance": "record",
          "stance_confidence": 0.72,
          "stance_reason": "record_observation",
          "text": "Led multistate litigation challenging rollback of ACA nondiscrimination protections: Becerra, with Massachusetts and New York attorneys general, led a coalition lawsuit against a Trump administration Section 1557 rule.",
          "theme_id": "health-care",
          "theme_label": "Health Care"
        }
      ],
      "evidence_groups": [
        {
          "candidate_id": "xavier-becerra",
          "candidate_name": "Xavier Becerra",
          "claim_ids": [
            "cl-app-event-xavier-becerra-2020-06-22-research-seed-led-multistate-litigat-7a4a5986"
          ],
          "claim_type": "observation",
          "date": "2020-06-22",
          "group_id": "idea:health-system-accountability:aca-nondiscrimination-enforcement:evidence:xavier-becerra:record:ab6c170a1a",
          "matched_keywords": [
            "aca",
            "coalition lawsuit",
            "litigation",
            "nondiscrimination",
            "rollback",
            "section 1557"
          ],
          "party": "Democratic",
          "row_count": 1,
          "source_count": 1,
          "source_rows": [
            {
              "claim_id": "cl-app-event-xavier-becerra-2020-06-22-research-seed-led-multistate-litigat-7a4a5986",
              "date": "2020-06-22",
              "event_id": "event-xavier-becerra-2020-06-22-research-seed-led-multistate-litigation-challe-da46bffc",
              "event_title": "Led multistate litigation challenging rollback of ACA nondiscrimination protections",
              "source_url": "https://www.oag.ca.gov/news/press-releases/attorney-general-becerra-files-lawsuit-challenging-trump-administration%E2%80%99s-rule-0",
              "text": "Led multistate litigation challenging rollback of ACA nondiscrimination protections: Becerra, with Massachusetts and New York attorneys general, led a coalition lawsuit against a Trump administration Section 1557 rule."
            }
          ],
          "stance": "record",
          "statement": "Led multistate litigation challenging rollback of ACA nondiscrimination protections: Becerra, with Massachusetts and New York attorneys general, led a coalition lawsuit against a Trump administration Section 1557 rule."
        }
      ],
      "evidence_quality": "record_only",
      "evidence_signal": "This is mostly record-backed legal enforcement, so it should be read as rights protection with limited current-campaign coverage.",
      "idea_id": "idea:health-system-accountability:aca-nondiscrimination-enforcement",
      "idea_kind": "rights",
      "idea_slug": "aca-nondiscrimination-enforcement",
      "issue_id": "health-system-accountability",
      "label": "ACA nondiscrimination enforcement",
      "matched_keywords": [
        {
          "count": 1,
          "keyword": "aca"
        },
        {
          "count": 1,
          "keyword": "coalition lawsuit"
        },
        {
          "count": 1,
          "keyword": "litigation"
        },
        {
          "count": 1,
          "keyword": "nondiscrimination"
        },
        {
          "count": 1,
          "keyword": "rollback"
        },
        {
          "count": 1,
          "keyword": "section 1557"
        }
      ],
      "party_aggregates": [
        {
          "candidate_count": 1,
          "claim_count": 1,
          "issue_candidate_count": 1,
          "party": "Democratic"
        }
      ],
      "plausibility": "Plausible when courts or agencies can restore clear rules; limited by federal policy and litigation timelines.",
      "problem": "Health access can be weakened when nondiscrimination protections are rolled back or unenforced.",
      "quality_flags": ["single_candidate", "single_source", "record_only"],
      "related_problem_links": [],
      "related_problems": ["Civil rights", "Health access", "Federal health policy"],
      "review_status": "generated_review_candidate",
      "semantic_group_id": "idea-group:health-system-accountability:market-and-program-enforcement",
      "semantic_group_label": "Market and program enforcement",
      "semantic_group_slug": "market-and-program-enforcement",
      "solution": "Use litigation, coalition action, or enforcement to protect ACA nondiscrimination and Section 1557 rules.",
      "source_count": 1,
      "stance_counts": {
        "oppose": 0,
        "qualify": 0,
        "record": 1,
        "support": 0,
        "unclear": 0
      },
      "summary": "Uses litigation or enforcement to protect ACA nondiscrimination and Section 1557 rules.",
      "tradeoffs": [
        "Can protect access for vulnerable groups, but legal wins may be slow and reversible.",
        "Rights enforcement does not solve affordability or provider capacity by itself."
      ],
      "variants": [
        {
          "candidate_count": 1,
          "claim_ids": [
            "cl-app-event-xavier-becerra-2020-06-22-research-seed-led-multistate-litigat-7a4a5986"
          ],
          "evidence_count": 1,
          "label": "aca",
          "matched_keyword": "aca",
          "matched_keywords": ["aca"],
          "slug": "aca",
          "source_count": 1,
          "variant_id": "idea:health-system-accountability:aca-nondiscrimination-enforcement:aca"
        },
        {
          "candidate_count": 1,
          "claim_ids": [
            "cl-app-event-xavier-becerra-2020-06-22-research-seed-led-multistate-litigat-7a4a5986"
          ],
          "evidence_count": 1,
          "label": "coalition lawsuit",
          "matched_keyword": "coalition lawsuit",
          "matched_keywords": ["coalition lawsuit"],
          "slug": "coalition-lawsuit",
          "source_count": 1,
          "variant_id": "idea:health-system-accountability:aca-nondiscrimination-enforcement:coalition-lawsuit"
        },
        {
          "candidate_count": 1,
          "claim_ids": [
            "cl-app-event-xavier-becerra-2020-06-22-research-seed-led-multistate-litigat-7a4a5986"
          ],
          "evidence_count": 1,
          "label": "litigation",
          "matched_keyword": "litigation",
          "matched_keywords": ["litigation"],
          "slug": "litigation",
          "source_count": 1,
          "variant_id": "idea:health-system-accountability:aca-nondiscrimination-enforcement:litigation"
        },
        {
          "candidate_count": 1,
          "claim_ids": [
            "cl-app-event-xavier-becerra-2020-06-22-research-seed-led-multistate-litigat-7a4a5986"
          ],
          "evidence_count": 1,
          "label": "nondiscrimination",
          "matched_keyword": "nondiscrimination",
          "matched_keywords": ["nondiscrimination"],
          "slug": "nondiscrimination",
          "source_count": 1,
          "variant_id": "idea:health-system-accountability:aca-nondiscrimination-enforcement:nondiscrimination"
        },
        {
          "candidate_count": 1,
          "claim_ids": [
            "cl-app-event-xavier-becerra-2020-06-22-research-seed-led-multistate-litigat-7a4a5986"
          ],
          "evidence_count": 1,
          "label": "rollback",
          "matched_keyword": "rollback",
          "matched_keywords": ["rollback"],
          "slug": "rollback",
          "source_count": 1,
          "variant_id": "idea:health-system-accountability:aca-nondiscrimination-enforcement:rollback"
        },
        {
          "candidate_count": 1,
          "claim_ids": [
            "cl-app-event-xavier-becerra-2020-06-22-research-seed-led-multistate-litigat-7a4a5986"
          ],
          "evidence_count": 1,
          "label": "section 1557",
          "matched_keyword": "section 1557",
          "matched_keywords": ["section 1557"],
          "slug": "section-1557",
          "source_count": 1,
          "variant_id": "idea:health-system-accountability:aca-nondiscrimination-enforcement:section-1557"
        }
      ]
    }
  ],
  "candidate_stances": [
    {
      "approach_id": "health-system-accountability--aca-nondiscrimination-enforcement",
      "candidate_id": "xavier-becerra",
      "candidate_name": "Xavier Becerra",
      "claim_count": 1,
      "claim_ids": [
        "cl-app-event-xavier-becerra-2020-06-22-research-seed-led-multistate-litigat-7a4a5986"
      ],
      "confidence": 0.72,
      "issue_id": "health-system-accountability",
      "party": "Democratic",
      "review_status": "generated_review_candidate",
      "source_count": 1,
      "stance": "record",
      "stance_counts": {
        "oppose": 0,
        "qualify": 0,
        "record": 1,
        "support": 0,
        "unclear": 0
      }
    },
    {
      "approach_id": "health-system-accountability--prescription-drug-pricing",
      "candidate_id": "xavier-becerra",
      "candidate_name": "Xavier Becerra",
      "claim_count": 2,
      "claim_ids": [
        "cl-app-event-2026-05-05-cnn-california-governor-primary-debate-xavier-becer-6195c223",
        "cl-app-event-xavier-becerra-2023-08-29-research-seed-oversaw-hhs-cms-implem-e0db9103"
      ],
      "confidence": 0.74,
      "issue_id": "health-system-accountability",
      "party": "Democratic",
      "review_status": "generated_review_candidate",
      "source_count": 2,
      "stance": "support",
      "stance_counts": {
        "oppose": 0,
        "qualify": 0,
        "record": 1,
        "support": 1,
        "unclear": 0
      }
    }
  ],
  "evidence_groups": [],
  "generated_at": "2026-06-02T08:01:06.314093+00:00",
  "idea_groups": [
    {
      "approach_ids": [
        "health-system-accountability--aca-nondiscrimination-enforcement",
        "health-system-accountability--prescription-drug-pricing"
      ],
      "candidate_count": 1,
      "candidate_summaries": [
        {
          "candidate_id": "xavier-becerra",
          "candidate_name": "Xavier Becerra",
          "claim_count": 3,
          "party": "Democratic",
          "source_count": 3,
          "stance": "support"
        }
      ],
      "claim_count": 3,
      "curation_note": "Codex semantic grouping over deterministic source-backed approach clusters; source rows remain attached to the child approaches.",
      "evidence_quality": "single_candidate",
      "group_id": "idea-group:health-system-accountability:market-and-program-enforcement",
      "group_kind": "approach",
      "group_slug": "market-and-program-enforcement",
      "idea_ids": [
        "idea:health-system-accountability:aca-nondiscrimination-enforcement",
        "idea:health-system-accountability:prescription-drug-pricing"
      ],
      "issue_id": "health-system-accountability",
      "label": "Market and program enforcement",
      "party_aggregates": [
        {
          "candidate_count": 1,
          "claim_count": 3,
          "issue_candidate_count": 1,
          "party": "Democratic"
        }
      ],
      "primary_approach_id": "health-system-accountability--prescription-drug-pricing",
      "primary_idea_slug": "prescription-drug-pricing",
      "quality_flags": ["record_only", "single_candidate", "single_source"],
      "review_status": "codex_curated_review_candidate",
      "source_count": 3,
      "stance_counts": {
        "oppose": 0,
        "qualify": 0,
        "record": 2,
        "support": 1,
        "unclear": 0
      },
      "summary": "Medi-Cal fraud, ACA enforcement, prescription drug pricing, and health-market accountability approaches."
    }
  ],
  "issue": {
    "analysis_questions": [
      "Which actor is being held accountable?",
      "Is the tool enforcement, litigation, price leverage, or market oversight?",
      "Does the source row show a current proposal or a prior record signal?"
    ],
    "approach_ids": [
      "health-system-accountability--prescription-drug-pricing",
      "health-system-accountability--aca-nondiscrimination-enforcement"
    ],
    "candidate_count": 1,
    "claim_count": 3,
    "coverage_summary": {
      "average_score": 24,
      "by_quality": {
        "record_only": 1,
        "single_candidate": 1
      },
      "warning": "Coverage summarizes normalized source rows only; missing rows are not opposition."
    },
    "idea_group_ids": ["idea-group:health-system-accountability:market-and-program-enforcement"],
    "issue_id": "health-system-accountability",
    "label": "Health System Accountability",
    "party_denominators": [
      {
        "candidate_count": 1,
        "party": "Democratic"
      }
    ],
    "problem_statement": "Health-system accountability rows focus on fraud, drug prices, nondiscrimination, and market oversight rather than the broader question of who is covered.",
    "summary": "Medi-Cal fraud enforcement, prescription drug prices, ACA protections, insurer conduct, and health-market oversight.",
    "theme_ids": ["health-care", "prescription-drugs"]
  },
  "limitations": [
    "This is a research prototype, not a voter guide, endorsement, or final assessment.",
    "Many rows are model-generated or unreviewed and should be treated as evidence-navigation aids.",
    "Missing or limited coverage means the dataset has not ingested, normalized, or balanced that surface yet; it is not evidence that a candidate lacks activity there.",
    "Use source URLs and record IDs when citing claims. Prefer the linked JSON/JSONL companion files for retrieval."
  ],
  "links": {
    "app_ideas": "https://polit.pages.dev/app/?view=ideas&issue=health-system-accountability",
    "app_issue": "https://polit.pages.dev/app/?view=issues&issue=health-system-accountability",
    "json": "https://polit.pages.dev/llm/issues/health-system-accountability.json",
    "markdown": "https://polit.pages.dev/llm/issues/health-system-accountability.md"
  },
  "schema_version": "llm-static-exports/v1",
  "stance_guide": {
    "oppose": {
      "description": "Source rows reject or argue against the selected approach statement.",
      "label": "Opposes this approach"
    },
    "qualify": {
      "description": "Source rows partly support, condition, or mix the selected approach with another claim.",
      "label": "Mixed / conditional signal"
    },
    "record": {
      "description": "Source rows describe a record signal rather than a current position.",
      "label": "Record-only signal"
    },
    "support": {
      "description": "Source rows back the selected approach statement.",
      "label": "Supports this approach"
    },
    "unclear": {
      "description": "Source rows mention the topic but do not clearly support or oppose the approach.",
      "label": "Unclear signal"
    }
  }
}